Gelteq Limited/$GELS
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Gelteq Limited
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.
Ticker
$GELS
Sector
Primary listing
Employees
8
Headquarters
Clayton, Australia
Website
Gelteq Limited Metrics
BasicAdvanced
$12M
-
-$0.48
-
-
Price and volume
Market cap
$12M
52-week high
$4.11
52-week low
$0.77
Average daily volume
2M
Financial strength
Current ratio
0.268
Quick ratio
0.143
Long term debt to equity
0.086
Total debt to equity
26.685
Interest coverage (TTM)
-2.67%
Profitability
EBITDA (TTM)
-2.552
Gross margin (TTM)
72.07%
Net profit margin (TTM)
-1,608.55%
Operating margin (TTM)
-1,226.46%
Revenue per employee (TTM)
$33,200
Management effectiveness
Return on assets (TTM)
-15.00%
Return on equity (TTM)
-42.99%
Valuation
Price to revenue (TTM)
36.844
Price to book
0.69
Price to tangible book (TTM)
-2.7
Price to free cash flow (TTM)
-2.469
Free cash flow yield (TTM)
-40.50%
Free cash flow per share (TTM)
-0.441
Growth
Revenue change (TTM)
188.27%
Earnings per share change (TTM)
63.64%
3-year revenue growth (CAGR)
3.55%
3-year earnings per share growth (CAGR)
16.11%
Gelteq Limited News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Gelteq Limited stock?
Gelteq Limited (GELS) has a market cap of $12M as of December 08, 2025.
What is the P/E ratio for Gelteq Limited stock?
The price to earnings (P/E) ratio for Gelteq Limited (GELS) stock is 0 as of December 08, 2025.
Does Gelteq Limited stock pay dividends?
No, Gelteq Limited (GELS) stock does not pay dividends to its shareholders as of December 08, 2025.
When is the next Gelteq Limited dividend payment date?
Gelteq Limited (GELS) stock does not pay dividends to its shareholders.
What is the beta indicator for Gelteq Limited?
Gelteq Limited (GELS) does not currently have a Beta indicator.